Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’...
Main Authors: | Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez, Michael Lanzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms15273 |
Similar Items
-
SC83288 is a clinical development candidate for the treatment of severe malaria
by: Stefano Pegoraro, et al.
Published: (2017-01-01) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01) -
Introduction to the IEEE <sc>Journal of</sc> <sc>Microwaves</sc>
by: Peter H. Siegel
Published: (2021-01-01) -
Erratum Erratum
by: Luiz M. Cangiani
Published: (2001-12-01) -
Erratum: “Measurement of the elastic tensor of SmScO3 and NdScO3 using resonant ultrasound spectroscopy with ab initio calculations” [AIP Advances 1, 032154 (2011)]
by: K. A. Pestka II, et al.
Published: (2011-12-01)